On Christmas Day, billionaire Elon Musk shocked his followers by sharing a revealing post about his weight-loss journey. Known for his outspoken personality, Musk posted a photo of himself dressed as Santa Claus on X, formerly known as Twitter, with the caption “Ozempic Santa.” He then clarified in the replies that while the drug he’s taking is technically Mounjaro, not Ozempic, he chose the more familiar name for its ring.
Musk's Christmas Post and the Secret Behind His Weight Loss
Musk’s candidness about using medication to shed pounds left many of his followers surprised, as he has always been an advocate for pushing boundaries, both in business and personal health. The post showed the Tesla and SpaceX CEO in a classic red-and-white Santa costume, accompanied by the playful phrase "Ozempic Santa." While the internet quickly buzzed about the medication’s popularity among celebrities, Musk clarified that he was actually using Mounjaro, a drug related to Ozempic, for weight loss.
Ozempic and Mounjaro are both injectable medications originally designed to treat type-2 diabetes. They have gained significant attention as anti-obesity treatments due to their ability to help individuals lose weight when combined with diet and exercise. Mounjaro, which contains the active ingredient tirzepatide, was approved by the U.S. Food and Drug Administration (FDA) in 2022 and has become a common choice for those struggling with obesity-related health issues such as high blood pressure, high cholesterol, and sleep apnea.
Mounjaro vs. Ozempic: How They Work and Their Growing Popularity
Both Ozempic and Mounjaro work by regulating insulin levels and suppressing appetite. The drugs have been lauded for their effectiveness in weight loss, with many people using them to shed significant amounts of weight. Mounjaro is considered more powerful than Ozempic due to its unique combination of drugs, but both are widely regarded as effective in the treatment of obesity and related conditions.
Musk’s admission comes after he had previously shared that he lost 30 pounds by combining fasting with Ozempic/Wegovy, another brand of the same active ingredient, semaglutide. The revelation has sparked widespread discussion on social media about the ethics and long-term effectiveness of using prescription medications for weight loss. Musk’s fans have embraced his transparency, but others have raised concerns about the potential risks of using these drugs for non-medical reasons.
Public Reaction to Musk's Post on X
The reaction to Musk’s post has been swift and divided. While some praised Musk for his honesty, others expressed skepticism. Many social media users found it amusing that Musk, who is known for his eccentric behavior, would embrace the “Ozempic Santa” persona. However, others questioned the influence of such posts, particularly when they involve prescription drugs that are not typically intended for widespread, casual use.
Here’s what some Twitter users had to say:
- @TechGuru2024: “Elon Musk’s Ozempic confession is not surprising, but it's funny to see him embrace the Santa look. #OzempicSanta”
- @HealthyLiving123: “Musk using Ozempic to lose weight? Must be nice to have access to these treatments. #Mounjaro #WeightLoss”
- @TheRealChrisJ: “I love how Musk is always willing to share his secrets, even the ones that might raise some eyebrows.”
- @GadgetsAndGains: “Do people realize how dangerous it can be to promote these meds for weight loss without medical supervision? #OzempicSanta”
- @MindYourBusiness21: “Elon Musk and Mounjaro, now that’s an unexpected combo. #BusinessAndHealth”
- @FuturiTechFan: “Musk’s transparency about his weight-loss methods is refreshing, but it’ll definitely stir the pot. #OzempicSanta”
What's Next for Musk and His Health Journey?
Musk’s weight-loss journey is far from over. As he continues to make headlines with his personal and professional endeavors, including his involvement in the newly created Department of Government Efficiency (DOGE), it remains to be seen how his decision to openly embrace weight-loss treatments will affect his public image. In the meantime, Musk’s followers can expect more surprises as he prepares for a major role in the upcoming administration and his next business ventures.


Oman Proposes Strait of Hormuz Plan as U.S. Rejects Iran Shipping Fee Idea
Lebanon Lawyers Seek Probe Into Banker Over Alleged Netanyahu Dinner in Washington
Trump Weighs Iran Strikes as U.S. Embassies Issue Emergency Security Alerts
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Trump-Backed Russia Sanctions Bill Faces House Hurdles Over Tariff Powers
White House: No Weaponized Drones Seized at FIFA World Cup Venues Despite 700 Recoveries
Iran Warns of Retaliation as Trump Threatens New Strikes, Oil Risks Intensify
Peru Court Frees Former President Ollanta Humala After Conviction Overturned
Trump Says U.S. ICC Campaign Aims to Protect Netanyahu, Not Himself
North Korea Warns U.S. Forces Japan Expansion Raises Korea Conflict Risk
New Jewish-Arab Party Seeks Young Voters Ahead of Israel Election Amid Debate Over Arab Vote
Brazil Supreme Court Approves Probe Into Lula’s Son Over Health Ministry Lobbying Claims
Trump Announces Hamas Disarmament Deal Under Gaza Peace Plan
UN Warns of Rising Israeli Settler Violence in West Bank as Palestinian Death Toll Grows
Capital One Says AML Review Led to Closure of Trump Organization Accounts
Spain Deploys Troops as Ceuta Faces Major Migrant Surge From Morocco 



